Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by subaru1on Apr 16, 2024 11:00am
77 Views
Post# 35991513

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:price being completely controlled held down.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:price being completely controlled held down.Thi is from Medipharm web.
Multiple Randomized Controlled Trials have recently been approved by Health Canada featuring MediPharm products in indications such as Depression related sleep disorders, Post surgical pain treatment, and Opioid Sparing in chronic pain

Anyone here knows which product they are, i don't think so, one of the problem with Labs is their I.R. Also a penny stock of $0,08 doesn't really interest the analyst and institution, even the big guys like Aurora, Ogi, Canopy, Tilray aren't interested to come with a buyout at our chesp price. It seems that even if Labs doesn't do good promotion, the buyers who dig into the stock aren't interested either, it is like a mistery. Labs will probably profitable this year but eventhough at that moment we will hit the $0,15 or may be $0,20 by y/e still if they don't promote the company we will be hanging at these level for a while. It seems that managment is sitting and waiting that one of the trial came out with a major impact.

P.S.: the only good thing i can see we have been going sideways for 2 years minimum now, usually the longer we go sideways when it breaks up or down thinks goes quick.
<< Previous
Bullboard Posts
Next >>